Drugs for Treating Raynaud’s

The Future of Off-Label Drugs and Their Value to Raynaud’s Sufferers

A recent editorial in the Wall Street Journal by Dr. Joseph V. Gulfo, author of Innovation Breakdown:  How the FDA and Wall Street Cripple Medical Advances, reviews recent developments in the approval practices associated with off-label drugs. For those not […]